Your Messages Inbox
Your Article Summary
See Latest ArticlesComparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration
Annals of Pharmacotherapy, 09/25/09
Davit BM et al. – The criteria used to evaluate generic drug bioequivalence studies support the FDA's objective of approving generic drug formulations that are therapeutically equivalent to their innovator counterparts.
Related Articles
Teva Receives Final Approval For Generic Prevacid Delayed-Release Capsules
Teva Pharmaceutical Industries, 11/11/09
Relevance Score: 68%
Cephalon Notified of Generic Filing for Armodafinil Tablets
Cephalon, 10/22/09
Relevance Score: 68%
Mylan Receives FDA Approval for Generic Version of Prevacid Through its Subsidiary Matrix Laboratories
Mylan, 11/11/09
Relevance Score: 67%
Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots
Diagnostic Microbiology and Infectious Disease, 10/22/09
Relevance Score: 67%
Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment SinemetÂ
Mylan, 10/01/09
Relevance Score: 67%
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09
Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09
Mylan Receives Approval for Generic Version of Antiepileptic Keppra 1000 mg
Mylan, 12/15/09
Article Search
Sponsor